Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
21.11
+0.11 (0.52%)
At close: Apr 28, 2026, 4:00 PM EDT
21.50
+0.39 (1.85%)
After-hours: Apr 28, 2026, 6:39 PM EDT
Syndax Pharmaceuticals Market Cap
Syndax Pharmaceuticals has a market cap or net worth of $1.86 billion as of April 28, 2026. Its market cap has increased by 105.74% in one year.
Market Cap
1.86B
Enterprise Value
1.80B
1-Year Change
105.74%
Ranking
Category
Stock Price
$21.11
Market Cap Chart
Since March 3, 2016, Syndax Pharmaceuticals's market cap has increased from $208.60M to $1.86B, an increase of 792.58%. That is a compound annual growth rate of 24.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.85B | 1.43% |
| Dec 31, 2025 | 1.83B | 61.83% |
| Dec 31, 2024 | 1.13B | -25.02% |
| Dec 29, 2023 | 1.50B | -1.81% |
| Dec 30, 2022 | 1.53B | 41.76% |
| Dec 31, 2021 | 1.08B | 18.96% |
| Dec 31, 2020 | 908.90M | 281.41% |
| Dec 31, 2019 | 238.30M | 115.66% |
| Dec 31, 2018 | 110.50M | -48.29% |
| Dec 29, 2017 | 213.70M | 63.88% |
| Dec 30, 2016 | 130.40M | -37.49% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trevi Therapeutics | 2.02B |
| Stoke Therapeutics | 2.01B |
| Mesoblast | 1.98B |
| Inhibrx Biosciences | 1.89B |
| Galapagos NV | 1.88B |
| Pharvaris | 1.87B |
| Recursion Pharmaceuticals | 1.85B |
| Taysha Gene Therapies | 1.84B |